Yang Baofeng (Academician of the Chinese Academy of Engineering, gave a speech on the theme Combination of Medicine & Engineering on preventing & controlling the major diseases in Beijing the headquarters of HMI Group on Jun, 5th , 2019.
Isabella Hao (CEO), Jimmy Chen (COO), William Ye (CMO), Eric Wang (GM of Hanyi Bio-tech), Persis Xing (President of Hanyi research institute) and all HMI Group staffs attended the activity.
Academician Yang Baofeng was the main rapporteur of 2035 Development Strategy. He explained details about the relationship of 2035 Development Strategy on Combination of Medicine & Engineering and preventing & controlling the chronic disease.
2035 Development Strategy focused on advancing the development of new diagnostic and therapeutic technologies based on sound, light, electricity and magnetism which is used on treating & preventing of cancer diseases.
It’s reported that there were 18.1 million new cancer cases worldwide, and 9.6 million people died of cancer. What’s more, China has become the world’s largest number of new cancer cases and deaths! How to effectively fight against cancer disease has become a difficult task for us. It’s the primary task of R&D team to apply accurate treatment methods to effectively treat and control tumor diseases.
At present, the application and development value of industrial hemp in the field of medicine have been proved. Academician Yang Baofeng explained in details the research on the anti-aging, anti-depression and analgesic effects of the non-psychoactive ingredients of industrial hemp carried out by his team in early stage and gave a positive outlook on the research direction in the future.
Academician Yang Baofeng fully affirmed the research work of HMI Group on non-psychoactive drugs of industrial hemp. HMI Group will continue to make technological breakthroughs in Combination of Medicine & Engineering on preventing & controlling the major diseases, maintain a forward-looking vision & diversified thinking, promote the transformation of the products, and make great contribution to the medical and health care in the future.
- ［Group News］HMI Group has reached strategic cooperation with Cross-strait Development Research Institute of Tsinghua University
- ［Group News］HMI GROUP ANNOUNCES STRATEGIC PARTNERSHIP AND INVESTMENT AGREEMENT WITH GEYSER BRANDS INC.
- ［Group News］HMI Group will attend MJBizCon at the Las Vegas Convention Center, December 11-13, 2019
- ［Group News］HMI Group Intends to Sell 51% Equity Interest in Suma Bio to Grandshores Technology Group for the Development of Industrial Hemp
- ［Group News］HMI Group Attends Global（China-Myanmar）Ecosystem Summit on Industrial Hemp Industry Development
- ［Group News］HMI Group ‘s New Products Conference CISOO E-cigarette
- ［Group News］HMI Group will attend CPhI worldwide 2019
- ［Group News］HMI Group cooperates with Kunming Agricultural Development & Investment Co., Ltd. and Yunnan Agricultural University on the development the whole chain of industrial hemp
- ［Group News］HMI Group (Kunming) Tech Center Established
- ［Group News］HMI Group attends USA CBD Expo 2019 in Miami Beach, Florida